We are live on
!
Find out more
AHS
Aspiriant Holdings S3 Portfolio holdings
AUM
$233M
1-Year Est. Return
3.13%
This Fund
S&P 500
This Quarter
Est. Return
+3.73%
1 Year Est. Return
-3.13%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$237M
AUM Growth
+$15.1M
(+6.8%)
Cap. Flow
+$7.24M
Cap. Flow
% of AUM
3.06%
Top 10 Holdings %
Top 10 Hldgs %
24.87%
Holding
109
New
12
Increased
52
Reduced
35
Closed
7
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoetis
ZTS
|
+$3.43M |
| 2 |
Johnson & Johnson
JNJ
|
+$3.37M |
| 3 |
eBay
EBAY
|
+$3.33M |
| 4 |
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
|
+$2.94M |
| 5 |
SCG
Scana
SCG
|
+$2.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
SPDR Gold Trust
GLD
|
+$6.18M |
| 2 |
COV
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
|
+$2.65M |
| 3 |
iShares MSCI Emerging Markets ETF
EEM
|
+$2.39M |
| 4 |
AbbVie
ABBV
|
+$2.29M |
| 5 |
iShares Global Tech ETF
IXN
|
+$1.35M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.15% |
| 2 | Financials | 12.93% |
| 3 | Healthcare | 9.24% |
| 4 | Energy | 8.06% |
| 5 | Consumer Discretionary | 7.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
101
iShares MSCI EAFE ETF
EFA
$79.5B
| $206K | 0.09% |
+3,235
| New | +$198K |
|
102
American Tower
AMT
$77.6B
| $203K | 0.09% |
2,739
-1,360
| -33% | -$98.2K |
|
103
Align Technology
ALGN
$12.4B
| – | – |
-10,472
| Closed | -$388K |
|
104
BCE
BCE
$20.4B
| – | – |
-5,035
| Closed | -$207K |
|
105
Becton Dickinson
BDX
$46.6B
| – | – |
-4,674
| Closed | -$451K |
|
|
106
iShares Global Tech ETF
IXN
$8.84B
| – | – |
-115,770
| Closed | -$1.35M |
|
107
Norfolk Southern
NSC
$76.3B
| – | – |
-3,940
| Closed | -$286K |
|
108
State Street Energy Select Sector SPDR ETF
XLE
$37.8B
| – | – |
-5,134
| Closed | -$201K |
|
|
COV
109
DELISTED
COVIDIEN PLC COM SHS NEW (IRELAND)
COV
| – | – |
-47,604
| Closed | -$2.65M |
|
Similar funds
SFU
BL
KM
TC
IA
QA
THP
SGH
Aspiriant Holdings S3's Q3 2013 Portfolio in Review
As of Q3 2013, Aspiriant Holdings S3 held 109 positions worth $237M, up 6.8% from $222M the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Aspiriant Holdings S3 deployed $7.24M of net new capital in Q3 2013, opening 12 new positions and adding to 52 existing holdings. Its largest new stake was Zoetis: 111,878 shares worth $3.48M.
By sector, the portfolio is most concentrated in Technology at 13% of assets, up from 13% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was SPDR Gold Trust, an estimated $6.18M trimmed.
- Aspiriant Holdings S3's largest Q3 2013 buy was Zoetis: 111,878 shares worth $3.48M.
- Aspiriant Holdings S3 added most to Johnson & Johnson in Q3 2013, an estimated $3.37M increase.
- Aspiriant Holdings S3's biggest Q3 2013 reduction was SPDR Gold Trust, cutting an estimated $6.18M.
- Aspiriant Holdings S3 fully exited COVIDIEN PLC COM SHS NEW (IRELAND) in Q3 2013, selling an estimated $2.65M.
- Aspiriant Holdings S3's ten largest holdings make up 25% of its $237M portfolio in Q3 2013.
- Aspiriant Holdings S3 opened 12 new positions and closed 7 in Q3 2013.
- Aspiriant Holdings S3's portfolio value rose 6.8% quarter-over-quarter to $237M.
Based on Aspiriant Holdings S3's 13F filing for Q3 2013, filed 5 Nov 2013.